MicroRNA-331-3p Suppresses Cervical Cancer Cell Proliferation and E6/E7 Expression by Targeting NRP2.

Abstract

Aberrant expression of microRNAs (miRNAs) is involved in the development and progression of various types of cancers. In this study, we investigated the role of miR-331-3p in cell proliferation and the expression of keratinocyte differentiation markers of uterine cervical cancer cells. Moreover, we evaluated whether neuropilin 2 (NRP2) are putative target molecules that regulate the human papillomavirus (HPV) related oncoproteins E6 and E7. Cell proliferation in the human cervical cancer cell lines SKG-II, HCS-2, and HeLa was assessed using the 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium, inner salt (MTS) assay. Cellular apoptosis was measured using the TdT-mediated dUTP nick end labeling (TUNEL) and Annexin V assays. Quantitative RT-PCR was used to measure the messenger RNA (mRNA) expression of the NRP2, E6, E7, p63, and involucrin (IVL) genes. A functional assay for cell growth was performed using cell cycle analyses. Overexpression of miR-331-3p inhibited cell proliferation, and induced G2/M phase arrest and apoptosis in SKG-II, HCS-2 and HeLa cells. The luciferase reporter assay of the NRP2 3'-untranslated region revealed the direct regulation of NRP2 by miR-331-3p. Gene expression analyses using quantitative RT-PCR in SKG-II, HCS-2, and HeLa cells overexpressing miR-331-3p or suppressing NRP2 revealed down-regulation of E6, E7, and p63 mRNA and up-regulation of IVL mRNA. Moreover, miR-331-3p overexpression was suppressed NRP2 expression in protein level. We showed that miR-331-3p and NRP2 were key effectors of cell proliferation by regulating the cell cycle, apoptosis. NRP-2 also regulates the expression of E6/E7 and keratinocyte differentiation markers. Our findings suggest that miR-331-3p has an important role in regulating cervical cancer cell proliferation, and that miR-331-3p may contribute to keratinocyte differentiation through NRP2 suppression. miR-331-3p and NRP2 may contribute to anti-cancer effects.

• Authors: Tomomi Fujii, Keiji Shimada, Aya Asano, Yoshihiro Tatsumi, Naoko Yamaguchi, Masaharu Yamazaki, Noboru Konishi
• Journal: International journal of molecular sciences (Int J Mol Sci) Vol. 17 Issue 8 (Aug 18 2016) ISSN: 1422-0067 [Electronic] Switzerland
• PMID: 27548144 (Publication Type: Journal Article)

Chemical References

• MIRN331 microRNA, human
• MicroRNAs
• Neuropilin-2
• Oncogene Proteins, Viral

Topics

• Cell Cycle (genetics, physiology)
• Cell Line, Tumor
• Cell Proliferation (genetics, physiology)
• Cell Survival (genetics, physiology)
• Female
• HeLa Cells
• Humans
• In Situ Nick-End Labeling
• Keratinocytes (cytology, metabolism)
• MicroRNAs (genetics, metabolism)
• Neuropilin-2 (genetics, metabolism)
• Oncogene Proteins, Viral (genetics, metabolism)
• Uterine Cervical Neoplasms (genetics, metabolism)